[1] MARK ABRAMOVITZ . The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs[J]. Biochimica et biophysica acta. Molecular and cell biology of lipids, 2000, 1483 2: Pages 285-293. DOI:
10.1016/s1388-1981(99)00164-x[2] D.F WOODWARD PHD. The Pharmacology of Bimatoprost (Lumigan)[J]. Survey of ophthalmology, 2001, 45: Pages S337-S345. DOI:
10.1016/s0039-6257(01)00224-7[3] BAHRAM RESUL PHD Johan S M, PHD Laszlo B P Goran Selén Phd. Structure-activity relationships and receptor profiles of some ocular hypotensive prostanoids[J]. Survey of ophthalmology, 1997, 41: Pages S47-S52. DOI:
10.1016/s0039-6257(97)80007-0[4] KIRK M MAXEY MD Jennifer L B Jennifer L Johnson MS. The Hydrolysis of Bimatoprost in Corneal Tissue Generates a Potent Prostanoid FP Receptor Agonist[J]. Survey of ophthalmology, 2002, 47: Pages S34-S40. DOI:
10.1016/s0039-6257(02)00323-5